mRNA and carcinoma
June 11, 2026
28 min
Full
63 of 364
June 11, 2026
mRNA and carcinoma
0:00 / 28:53
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Dr John Campbell Episodes Around June 11, 2026
Episode 63 of 364 — walk the feed in the order it was published.
28:53This episodemRNA and carcinoma
Summary
MRNA vaccines and cancer
https://www.oncotarget.com/article/28827/text
Article investigates the potential association between modified mRNA (modRNA) COVID-19 vaccinations and the development of haematopoietic cancers.
Censorship in science
https://www.oncotarget.com/article/28829/text
Only relentless determination gets dissenting data published in peer-reviewed journals
https://panagispolykretis.substack.com/p/only-relentless-determination-gets
Case Study
Healthy, young, athletic woman who,
developed acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma (LBL),
following her second dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty®), (July 2021)
Drugs and Total Body Irradiation (TBI)
April, 2025, cell transplant from an unrelated donor.
Part of an expanding body of literature documenting similar occurrences after modRNA vaccinations.
30 papers describe malignancies that developed in close temporal relationship
with modRNA COVID-19 vaccinations.
(Often just a few days)
with 28 focusing on haemato-lymphoproliferative disorders.
In lymphoma, 4 cases, four cases showed onset at the inoculation site, three cases manifested in draining lymph nodes
Japan, leukaemia, breast, pancreatic, and lip/oral/ pharyngeal cancers increased significantly in 2022
https://pubmed.ncbi.nlm.nih.gov/38721172/
critical literature gap: the absence of population studies verifying cancer incidence by vaccination status in order to estimate the true cancer incidence or mortality increases following COVID-19 vaccination.
https://pubmed.ncbi.nlm.nih.gov/38933341/
‘technically pro-drug gene therapies encased in lipid
nanoparticles (LNPs), rather than natural naked mRNA.
Emerging evidence suggests that the biodistribution and persistence of modRNA, facilitated by lipid nanoparticles, can affect various tissues and organs,
including the bone marrow and other blood-forming organs.
Unfettered access through most tissues and organs,
Notably, modRNA vaccines exhibit a particular affinity for the bone marrow,
potentially influencing the immune system at multiple levels and,
triggering both autoimmune disorders and neoplastic processes.
By integrating clinical observations and current research,
we aim to provide valuable insights into the potential carcinogenic outcomes associated with modRNA vaccination.
Cancer causing Mechanisms